Additionally, the performance of SHOX2 methylation in formalin-fixed, paraffin-embedded (FFPE) samples was evaluated, showing a sensitivity of 78.1% and a specificity of 92.1% in distinguishing lung cancer from benign lesions [5]. This evidence concerns the gene SHOX2 and lung carcinoma.